Anna Vasilaki, Ph.D

Assistant Professor of Pharmacology

Faculty of Medicine

University of Thessaly

Email: a.vasilaki@med.uth.gr

 

Research Interests

1.                  Investigation of the neuroprotective properties of neuroactive compounds on retinal and CNS neurotransmission under various metabolic insults

2.                  Validation of neuroactive compounds for the treatment of age-related macular degeneration

3.                  Validation of the anti-inflammatory and antioxidant potential of neuroactive compounds for the treatment of micro-angiopathy during diabetic retinopathy

 

Recent Publications

 

1.                  Vasilaki A. and Thermos, K. (2009) Somatostatin analogues as therapeutics in retinal disease. Pharmacology & Therapeutics 122:324-33

2.                  Pallis E., 1Vasilaki A. , Fehlmann D., Kastellakis A., Hoyer D., Spyraki C., and Thermos K. (2009) Antidepressants influence somatostatin levels and receptor pharmacology in brain. Neuropsychopharmacology, 34:952-63.

3.                  Hatziefthimiou A., Kiritsi M., Kyropoulou A., Vasilaki A., Sakellaridis N. and Molyvdas P-A. (2009) Regional differences in the modulatory role of airway epithelium. Clinical and Experimental Pharmacology and Physiology, 36:668-74

4.                  Kouvaras E., Asprodini E.K., Asouchidou I., Vasilaki A., Kilindris T., Michaloudis D., Koukoutianou I., Papatheodoropoulos C., and Kostopoulos G. (2008) Fentanyl treatment reduces GABAergic inhibition in the CA1 area of the hippocampus 24h after acute exposure to the drug. Neuropharmacology, 55:1172-82

5.                  Mastrodimou N., 1Vasilaki A., Papadioti A., Kaforou S., Low M., Hoyer D. and Thermos K. (2006) Somatostatin receptors in wild type and somatostatin deficient mice and their involvement in nitric oxide physiology. Neuropeptides, 40:365373

1Equal contribution with the First Author